intravenous acyclovir , administered early in the course of hsv and vzv infection at dosages of 250 mg/m2 and 500 mg/m2 every eight hours , respectively , has nearly eliminated the risk of severe symptomatic pneumonitis .
C0001367
acyclovir
C0019348
hsv